The Duodenal Biopsy: Why Celiac Diagnosis Ends With a Scope

Why does celiac diagnosis end with a biopsy?

Because the antibodies and the damage are two different facts, and only one of them is the disease. The current ACG guideline puts tissue transglutaminase IgA — tTG-IgA — together with a total IgA level as the preferred first-line test, and has duodenal biopsy confirm the diagnosis in most adults 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tTG-IgA with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. NIDDK describes the same two-step sequence in plain terms: blood antibody tests first, then a biopsy of the small intestine 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Diagnosis of Celiac Disease.The patient-facing two-step diagnostic sequence: blood antibody tests followed by a biopsy of the small intestine..

The reason for the second step is that a diagnosis of celiac disease commits a person to a lifelong change, and it is worth being right. A celiac blood panel can be positive in someone whose intestine turns out to be intact, and the antibody level does not reliably tell you how much damage there is. The biopsy answers a question the blood cannot: what state is the lining actually in, right now.

The blood test asks whether the immune system is reacting. The biopsy asks what that reaction has done. A celiac diagnosis in an adult usually needs both answers.

That second answer keeps earning its keep long after diagnosis day. It is the baseline a later scope gets compared against, and it is what separates celiac disease from the conditions resembling it. Whether it is IBS or celiac, for instance, is the kind of question a normal duodenum settles and an ambiguous antibody level does not.

Gluten has to still be in the diet when the biopsy happens

This is the single most consequential thing on this page, and it is the thing most often got wrong before anyone reaches a gastroenterologist. The ACG guideline is explicit that celiac testing has to be done while the patient is eating a gluten-containing diet 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tTG-IgA with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. NIDDK says the same to patients directly: testing for celiac disease comes before starting a gluten-free diet, because avoiding gluten beforehand can make the results inaccurate 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Eating, Diet, & Nutrition for Celiac Disease.That celiac testing comes before starting a gluten-free diet because avoiding gluten beforehand can make results inaccurate, and that a gluten-free diet is the treatment..

The mechanism is straightforward and rather cruel. Celiac damage is driven by gluten. Remove gluten and the intestine begins to heal and the antibodies begin to fall — which is the whole point of the treatment, and precisely what ruins the test. Someone who has been gluten-free for months may have a normal biopsy and a normal antibody panel, and still have celiac disease. The tests will have measured a treated intestine and reported that nothing is wrong with it.

This is why gluten before celiac testing gets its own conversation. It matters most for the very people most likely to have tried the diet already: someone who felt better without bread has the strongest reason to want an answer and has usually already destroyed the means of getting one.

Going back onto gluten afterward — a gluten challenge — is possible, and uncomfortable enough to be worth planning with a clinician rather than improvising. How much and for how long is judged case by case.

What the endoscopy actually reaches and samples

An upper endoscopy passes a thin flexible camera through the mouth, down the esophagus, through the stomach, and into the duodenum — the first stretch of small intestine, just past the stomach outlet. That is where celiac disease does its damage, because it is where gluten arrives first and in the highest concentration. The scope stops there; this exam has nothing to do with the colon.

The gastroenterologist takes several small pieces of tissue rather than one, and from more than one location, because celiac damage can be patchy enough that a single sample lands on a stretch that looks fine while the tissue beside it does not. Sampling multiple sites, including the very first part of the duodenum, is what makes a normal result trustworthy.

The biopsies do not hurt. The intestinal lining has no somatic pain fibres of the kind that make a cut in the skin hurt; the tissue is taken with tiny forceps through the scope, and people feel nothing at the time or afterward. What discomfort an upper endoscopy causes comes from the scope and the air used to open the folds, not from the sampling.

The biopsy is the part of this procedure people worry about most and notice least. It is painless, it takes seconds, and it adds essentially nothing to the recovery.

What the pathologist is looking for

The duodenal lining is not smooth. It is carpeted in villi — fine finger-like projections that multiply the absorbing surface enormously — and celiac disease flattens them. Villous atrophy is that flattening, the finding at the centre of the diagnosis, though not the only thing the pathologist reads. Three features are assessed together, and they tend to appear in sequence as the disease progresses:

• Intraepithelial lymphocytes — immune cells infiltrating the surface layer. The earliest change, and on its own the least specific.
• Crypt hyperplasia — the tissue at the base of the villi working overtime to replace what is being lost.
• Villous atrophy — the flattening itself, ranging from partial blunting to a surface that has gone essentially flat.

The Marsh classification is the scheme pathologists use to describe where along that spectrum a sample sits, and it is why a celiac biopsy report often carries a Marsh grade rather than a plain yes or no. It is a description of severity, not a separate test.

The grade is worth understanding for what it does not mean. It describes the tissue, not the person: how ill someone feels tracks the biopsy poorly in both directions, and a substantially damaged intestine can belong to someone with almost no digestive symptoms at all. The Marsh grade is a starting line, not a verdict on how bad the disease is going to be.

Most celiac biopsies happen during a scope booked for something else

This surprises people, but a large share of adult celiac diagnoses begin with an endoscopy arranged for reflux, dyspepsia, or anemia rather than for suspected celiac disease at all. The duodenum is on the route, the gastroenterologist is already there, and biopsies get taken when the picture warrants it.

The thresholds for booking those scopes are set by their own guidelines. For dyspepsia, ACG and CAG recommend test-and-treat for H. pylori or an empiric acid-suppression trial in people under 60 without alarm features, and reserve upper endoscopy for those aged 60 and over or with alarm features such as weight loss, bleeding, or difficulty swallowing 4Ref 4Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N (2017).ACG and CAG Clinical Guideline: Management of Dyspepsia.The age and alarm-feature threshold for upper endoscopy in dyspepsia: test-and-treat or empiric acid suppression under 60 without alarm features, endoscopy at 60 and over or with alarm features such as weight loss, bleeding, or dysphagia.. For reflux, ACG recommends an eight-week empiric once-daily PPI trial for classic heartburn and regurgitation without alarm features, with endoscopy — performed off PPI therapy — for people who do not respond, who have alarm symptoms, or who are at risk of Barrett's esophagus 5Ref 5Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022).ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.The empiric eight-week once-daily PPI trial for classic reflux without alarm features, and the indications for endoscopy performed off PPI — non-response, alarm symptoms, or Barrett's risk..

When reflux needs a scope has its own detailed answer elsewhere. The point here is narrower: those ACG endoscopy alarm features are why a great many people end up in the room at all, and celiac disease is one of the things found once they are.

Celiac also has a skin manifestation that follows a different route entirely. Dermatitis herpetiformis — an intensely itchy, blistering rash — is assessed by dermatology on its own terms rather than through the duodenum.

Is this the same as a colonoscopy?

No, and the confusion is worth clearing up because the two exams get spoken about interchangeably and they are not remotely the same experience. A colonoscopy examines the colon from the other end. It requires a bowel prep and a clear-liquid diet beforehand, is done under sedation, usually takes under an hour, allows polyps to be removed or biopsied during the exam, and requires someone to drive you home afterward 6Ref 6National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2021).Colonoscopy.What a colonoscopy involves — bowel prep and clear-liquid preparation, sedation, usually under an hour, polyp removal or biopsy during the exam, and the need for a ride home — used here to contrast it with upper endoscopy..

An upper endoscopy for celiac disease shares almost none of that. There is no bowel prep — the preparation is fasting, not laxatives, and that difference alone is what most people are actually asking about when they ask what to expect. It is also quicker.

What the two do share is the sedation, and therefore the ride home. Anyone sedated for a procedure needs someone else to drive, and that is worth arranging in advance rather than discovering on the day.

Some people have both exams booked in one sedation session, which happens when there are questions at both ends — anemia being the classic reason to look in both directions at once. That is worth raising with the gastroenterologist beforehand rather than assuming either way.

When the blood test and the biopsy disagree

It happens, and it is not a dead end. A positive antibody panel with a normal-looking biopsy, or a suggestive biopsy with negative serology, sends the gastroenterologist back through a short list of explanations rather than to a coin flip. The commonest by far is the diet: gluten intake too small or too brief before testing quietly moves both results the same way.

The rest are structural. The tTG-IgA test is an IgA antibody, which is why the guideline pairs it with a total IgA level 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tTG-IgA with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults. — someone who makes little IgA overall can produce a falsely reassuring tTG-IgA whatever their intestine is doing. Sampling matters too, since patchy damage can be missed. And a flattened duodenum is not unique to celiac disease, which is one reason the diagnosis rests on antibodies and tissue together rather than either alone.

Results typically take one to two weeks, because the tissue has to be processed, sectioned, stained, and read. If the answer is celiac disease, the treatment is a gluten-free diet 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Eating, Diet, & Nutrition for Celiac Disease.That celiac testing comes before starting a gluten-free diet because avoiding gluten beforehand can make results inaccurate, and that a gluten-free diet is the treatment., and the referral that matters most at that point is usually to a dietitian rather than back to the scope.

If the answer is unclear, the next step is working out which of the reasons above applies — most often, the diet before the test. That is a fixable problem, fixed by repeating the sequence properly rather than settling for an ambiguous result.